NCT05471908 Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
| NCT ID | NCT05471908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Pneumonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,674 participants |
| Start Date | 2022-08-22 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,674 participants in total. It began in 2022-08-22 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections.
Eligibility Criteria
Inclusion Criteria: * Age \<18 years at the time of randomization * Hospitalization due to a primary diagnosis of pneumonia, skin and soft tissue infection, acute gastroenteritis, or urinary tract infection. * Parent speaks English or Spanish. Exclusion Criteria: * Presence of a comorbid disease that is both chronic and complex * Principal disease required surgical intervention (beyond superficial incision and drainage) * Immunodeficiency * A well-child check-up or post-hospitalization follow-up visit is already scheduled within 7 days of hospital discharge * Parent or participant strongly prefers PRN or automatic follow-up * A medical provider feels strongly that a post-hospitalization follow-up visit is needed within 7 days of hospital discharge * Sibling concurrently hospitalized * Unable to identify a clinic where the participant would receive any needed post-hospitalization follow-up * Diagnosis of pneumonia complicated by: o Receiving a chest tube * Diagnosis of urinary tract infection complicated by: * History of neurogenic bladder or urologic surgery * Renal imaging anticipated within 7 days of hospital discharge * Renal abscess * Diagnosis of skin and soft tissue infection complicated by: * Chronic wound * Postoperative infection * Predisposition to poor wound healing * Discharging with a drain in place * Complicated by necrotizing fasciitis or toxic shock syndrome * Diagnosis of gastroenteritis complicated by: * Hemolytic uremic syndrome
Contact & Investigator
Eric Coon, MD
PRINCIPAL INVESTIGATOR
University of Utah
Frequently Asked Questions
Who can join the NCT05471908 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05471908 currently recruiting?
Yes, NCT05471908 is actively recruiting participants. Contact the research team at Eric.Coon@hsc.utah.edu for enrollment information.
Where is the NCT05471908 trial being conducted?
This trial is being conducted at Phoenix, United States, Mountain View, United States, Palo Alto, United States, St Louis, United States and 10 additional locations.
Who is sponsoring the NCT05471908 clinical trial?
NCT05471908 is sponsored by University of Utah. The principal investigator is Eric Coon, MD at University of Utah. The trial plans to enroll 2,674 participants.